710 related articles for article (PubMed ID: 27385177)
101. Intestinal drug transporters: in vivo function and clinical importance.
Kunta JR; Sinko PJ
Curr Drug Metab; 2004 Feb; 5(1):109-24. PubMed ID: 14965254
[TBL] [Abstract][Full Text] [Related]
102. Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans.
Momper JD; Tsunoda SM; Ma JD
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S82-98. PubMed ID: 27385182
[TBL] [Abstract][Full Text] [Related]
103. Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics.
Ghanem CI; Manautou JE
Curr Med Chem; 2019; 26(7):1185-1223. PubMed ID: 29473496
[TBL] [Abstract][Full Text] [Related]
104. Effects of chronic renal failure on liver drug transporters.
Naud J; Michaud J; Leblond FA; Lefrancois S; Bonnardeaux A; Pichette V
Drug Metab Dispos; 2008 Jan; 36(1):124-8. PubMed ID: 17940133
[TBL] [Abstract][Full Text] [Related]
105. Multiple ABC Transporters Efflux Baicalin.
Kalapos-Kovács B; Magda B; Jani M; Fekete Z; Szabó PT; Antal I; Krajcsi P; Klebovich I
Phytother Res; 2015 Dec; 29(12):1987-90. PubMed ID: 26400418
[TBL] [Abstract][Full Text] [Related]
106. Role of transport proteins in drug absorption, distribution and excretion.
Ayrton A; Morgan P
Xenobiotica; 2001; 31(8-9):469-97. PubMed ID: 11569523
[TBL] [Abstract][Full Text] [Related]
107. Transport mechanisms at the pulmonary mucosa: implications for drug delivery.
Nickel S; Clerkin CG; Selo MA; Ehrhardt C
Expert Opin Drug Deliv; 2016; 13(5):667-90. PubMed ID: 26909544
[TBL] [Abstract][Full Text] [Related]
108. Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1.
Nakagomi-Hagihara R; Nakai D; Tokui T; Abe T; Ikeda T
Xenobiotica; 2007 May; 37(5):474-86. PubMed ID: 17523051
[TBL] [Abstract][Full Text] [Related]
109. A Study on Pharmacokinetics of Bosentan with Systems Modeling, Part 1: Translating Systemic Plasma Concentration to Liver Exposure in Healthy Subjects.
Li R; Niosi M; Johnson N; Tess DA; Kimoto E; Lin J; Yang X; Riccardi KA; Ryu S; El-Kattan AF; Maurer TS; Tremaine LM; Di L
Drug Metab Dispos; 2018 Apr; 46(4):346-356. PubMed ID: 29330218
[TBL] [Abstract][Full Text] [Related]
110. What do drug transporters really do?
Nigam SK
Nat Rev Drug Discov; 2015 Jan; 14(1):29-44. PubMed ID: 25475361
[TBL] [Abstract][Full Text] [Related]
111. Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics.
Ambrus C; Bakos É; Sarkadi B; Özvegy-Laczka C; Telbisz Á
Sci Rep; 2021 Sep; 11(1):17810. PubMed ID: 34497279
[TBL] [Abstract][Full Text] [Related]
112. Correlation between Conjugated Bisphenol A Concentrations and Efflux Transporter Expression in Human Fetal Livers.
Moscovitz JE; Nahar MS; Shalat SL; Slitt AL; Dolinoy DC; Aleksunes LM
Drug Metab Dispos; 2016 Jul; 44(7):1061-5. PubMed ID: 26851240
[TBL] [Abstract][Full Text] [Related]
113. Effects of Drug Transporters on Pharmacological Responses and Safety.
Liu CX; Yi XL; Fan HR; Wu WD; Zhang X; Xiao XF; He X
Curr Drug Metab; 2015; 16(9):732-52. PubMed ID: 26630905
[TBL] [Abstract][Full Text] [Related]
114. Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics.
Yamazaki M; Suzuki H; Sugiyama Y
Pharm Res; 1996 Apr; 13(4):497-513. PubMed ID: 8710738
[TBL] [Abstract][Full Text] [Related]
115. Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics.
Pfeifer ND; Hardwick RN; Brouwer KL
Annu Rev Pharmacol Toxicol; 2014; 54():509-35. PubMed ID: 24160696
[TBL] [Abstract][Full Text] [Related]
116. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
Mao Q; Lai Y; Wang J
Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
[TBL] [Abstract][Full Text] [Related]
117. Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity.
Pan G
Adv Exp Med Biol; 2019; 1141():293-340. PubMed ID: 31571168
[TBL] [Abstract][Full Text] [Related]
118. [Role of drug transporters in rational use of drugs
at high altitude area].
Li W; Yan B; Wang R; Jia Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 43(3):327-332. PubMed ID: 29701197
[TBL] [Abstract][Full Text] [Related]
119. Targeting intestinal transporters for optimizing oral drug absorption.
Varma MV; Ambler CM; Ullah M; Rotter CJ; Sun H; Litchfield J; Fenner KS; El-Kattan AF
Curr Drug Metab; 2010 Nov; 11(9):730-42. PubMed ID: 21189135
[TBL] [Abstract][Full Text] [Related]
120. Total hepatocellular disposition profiling of rosuvastatin and pitavastatin in sandwich-cultured human hepatocytes.
Kanda K; Takahashi R; Yoshikado T; Sugiyama Y
Drug Metab Pharmacokinet; 2018 Jun; 33(3):164-172. PubMed ID: 29724614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
